FDA calendar · July 2020 · built from SEC filings

PDUFA dates July 2020: FDA calendar and catalysts.

Updated Snapshot 20261116T222116ZBuilt

0 PDUFA dates fell in July 2020. The FDA calendar also recorded 20 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

PDUFA dates in July 2020

No PDUFA dates are disclosed for this period as of November 16, 2026.

Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months

July 2020: other FDA decisions and filings

DateDrugCompanyEventIndicationStatusSource
July 2, 2020Rukobia (fostemsavir tromethamine)GSKFDA approval—ApprovedopenFDA Drugs@FDA
July 6, 2020Kisqali Femara Co-Pack (Copackaged) (letrozole; ribociclib succinate)NVSLabel expansion—ApprovedopenFDA Drugs@FDA
July 6, 2020KISQALI® (ribociclib)NVSLabel expansion—ApprovedopenFDA Drugs@FDA
July 6, 2020Hulio (adalimumab-fkjp)VTRSFDA approval—ApprovedopenFDA Drugs@FDA
July 8, 2020Botox Cosmetic (onabotulinumtoxina)ABBVLabel expansion—ApprovedopenFDA Drugs@FDA
July 13, 2020Pataday Twice Daily Relief (olopatadine hydrochloride)ALCLabel expansion—ApprovedopenFDA Drugs@FDA
July 13, 2020Tremfya (guselkumab)JNJLabel expansion—ApprovedopenFDA Drugs@FDA
July 13, 2020YCANTH (cantharidin)VRCAComplete Response Letter—CRL issuedFDA Complete Response Letters
July 14, 2020Epclusa (sofosbuvir; velpatasvir)GILDLabel expansion—ApprovedopenFDA Drugs@FDA
July 14, 2020Juluca (dolutegravir sodium; rilpivirine hydrochloride)GSKLabel expansion—ApprovedopenFDA Drugs@FDA
July 14, 2020Isentress (raltegravir potassium)MRKLabel expansion—ApprovedopenFDA Drugs@FDA
July 21, 2020Xywav (calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate)JAZZFDA approval—ApprovedopenFDA Drugs@FDA
July 23, 2020Breztri Aerosphere (budesonide; formoterol fumarate; glycopyrrolate)AZNFDA approval—ApprovedopenFDA Drugs@FDA
July 23, 2020Jadenu (deferasirox)NVSLabel expansion—ApprovedopenFDA Drugs@FDA
July 28, 2020Faslodex (fulvestrant)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
July 29, 2020Nerlynx (neratinib maleate)PBYILabel expansion—ApprovedopenFDA Drugs@FDA
July 30, 2020Cyclophosphamide (cyclophosphamide)RDYFDA approval—ApprovedopenFDA Drugs@FDA
July 31, 2020Evotaz (atazanavir sulfate; cobicistat)BMYLabel expansion—ApprovedopenFDA Drugs@FDA
July 31, 2020Prezcobix (cobicistat; darunavir ethanolate)JNJLabel expansion—ApprovedopenFDA Drugs@FDA
July 31, 2020Spravato (esketamine hydrochloride)JNJLabel expansion—ApprovedopenFDA Drugs@FDA

July 2020: dated readouts

No events in this view.

Questions

What PDUFA dates are in July 2020?

0 PDUFA dates fell in July 2020. The FDA calendar also recorded 20 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

Can these dates change?

Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.

Built from primary public sources only: sponsor SEC filings (8-K, EX-99.1, 10-Q, 10-K), the FDA advisory committee calendar, FDA Novel Drug Approvals and Complete Response Letter records, openFDA, and ClinicalTrials.gov (U.S. National Library of Medicine). Every row links the sentence it came from. Dates move; the linked source is authoritative. Not investment or medical advice.

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.